Tonight on Nightly Business Report, Amgen spends more than $10b to buy Onyx Pharmaceuticals giving it access to the fast-growing market for cancer drugs. Is this the start of a wave of biotech deals?
And, NBR will tell you why a growing number of parents are struggling to pay off not only their own college loans, but also their children’s.
About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
NBR on TwitterMy Tweets
Subscribe to RSS